David McDonald has instilled a tremendous aspiration for growth since joining OSI Group 30 years ago. He has ensured that OSI Group maintains that growing appetite to date. OSI Group is anchored on a constant desire to improve and expand. Its vision is to become a global leader and valued partner to its clients. What drives OSI Group’s growth is its relentless push to deliver quality products to its clients. The team at OSI Group has an overall expectation that it will exceed its customer’s needs. However, for both partners to receive mutual rewards, it will require OSI Group to establish flexibility, trust, and patience over time. OSI Group is a privately-held corporation that strives to provide more nimble and flexible solutions.

OSI Group began with building formal partnerships. It would look for partners who understands the culture in their respective regions. Together with its business associates, OSI Group created a governance that would oversee its global operations. Nonetheless, OSI Group makes best management decisions closest to its customers. As such, most of its everyday decisions are made by its partners. OSI Group is inspired to be innovative by its clients. OSI Group feels inspired when a customer challenges it to respond to a business need. Over time, OSI Group has been using its innovative food development processes, customer insights, and global sourcing experience to provide its customers with unique products. Collaboration with customers leads OSI Group to additional refinements and improvements, resulting in a custom, innovative products. OSI Group measures its effectiveness through failures and mistakes. It is through this errors and failures that OSI Group can learn valuable lessons. OSI Group encourages all its team members to be risk takers. Its innovation is fuelled by a constant quest for improvement and commitment to improving its production processes.

OSI Group regard failure as an essential learning experience, but not a negative consequence. OSI Group continues to thrive in a family-oriented culture. OSI views its customers as part of its family. It strives to produce quality products to serve its respective families proudly. Quality and safety remain hallmarks of products that OSI Group supplies to its families and customers around the world. Adapting to change has always ensured that OSI Group continuous to thrive in the global marketplace. Keeping current with changes gives OSI Group a competitive advantage. Consumers tastes and needs keep changing over time. Consumers wants different things at different places and times.

For more info: www.google.com/finance?cid=12218761

Eric Lefkofsky is an inveterate entrepreneur, having been involved in at least six start-ups in his career, not least of which was Groupon. Some of his other endeavors include the startup of Lightbank, Uptake Technologies, MediaOcean, Echo Global Logistics and InnerWorkings.

In 2007 Mr. Lefkofsky co-founded and helped fund ThePoint.com. In 2008 thePoint became Groupon.com. Eric Lefkofsky was named CEO of that company in August of 2013.

Still Chairman at Groupon, he left his position as CEO in 2015 to be Co-Founder and CEO of Tempus in Chicago. Tempus is taking on the huge task of data mining and sequencing for cancer research.

Eric Lefkofsky sees that one of the biggest problems in cancer research is that there is not one place where all of the data is collected and cleaned. He and his colleagues believe that knowledge that will lead towards improved cancer care can be gleaned from information found in a big enough data bank.

The mission of Tempus is to bring all of the data that has been collected by clinicians to one place. When there is enough data patterns can be seen. These patterns can then be studied and analyzed by doctors and pharmaceutical companies and biotech engineers. Eventually this analysis will lead to more precise cancer therapies. Until now, there has not been a system set up to maximize all of the data that has been stored in different places.

The kinds of information that is being culled includes: which drug was given to which patient? What was the response? What other biological data is there? There is also information from imaging and biotech companies and pharmaceuticals — all of the stake holders in Cancer research.

Mr. Lefkofsky’s other interests are wide and deep. He sits on several Boards of Directors in Chicago. This list includes Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry and World Business Chicago. He is also Board Chairman at Steppenwolf Theatre Company.

Eric is also an educator. In addition, he and his wife manage the Lefkofsky Family Foundation, a charitable organization.